Net Income (Loss) Attributable to Parent in USD of Larimar Therapeutics, Inc. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Larimar Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q3 2025.
  • Larimar Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$47.7M, a 208% decline year-over-year.
  • Larimar Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$132M, a 104% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$80.6M, a 118% decline from 2023.
  • Larimar Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$36.9M, a 4.51% decline from 2022.
  • Larimar Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35.4M, a 30.2% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Larimar Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$132M -$47.7M -$32.2M -208% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$99.8M -$26.2M -$4.56M -21.1% 01 Apr 2025 30 Jun 2025 10-Q 05 Nov 2025
Q1 2025 -$95.2M -$29.3M -$14.6M -99.8% 01 Jan 2025 31 Mar 2025 10-Q 05 Nov 2025
Q4 2024 -$80.6M -$28.8M -$15.8M -122% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025
Q3 2024 -$64.8M -$15.5M -$6.44M -71% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$58.3M -$21.6M -$13.3M -159% 01 Apr 2024 30 Jun 2024 10-Q 05 Nov 2025
Q1 2024 -$45.1M -$14.7M -$8.13M -125% 01 Jan 2024 31 Mar 2024 10-Q 05 Nov 2025
Q4 2023 -$36.9M -$13M -$3.57M -37.9% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025
Q3 2023 -$33.4M -$9.06M -$744K -8.94% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 -$32.6M -$8.37M +$301K +3.47% 01 Apr 2023 30 Jun 2023 10-Q 30 Oct 2024
Q1 2023 -$32.9M -$6.53M +$2.42M +27% 01 Jan 2023 31 Mar 2023 10-Q 30 Oct 2024
Q4 2022 -$35.4M -$9.43M -$291K -3.19% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 -$35.1M -$8.32M +$8.49M +50.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$43.5M -$8.67M +$3.94M +31.3% 01 Apr 2022 30 Jun 2022 10-Q 14 Nov 2023
Q1 2022 -$47.5M -$8.94M +$3.15M +26% 01 Jan 2022 31 Mar 2022 10-Q 14 Nov 2023
Q4 2021 -$50.6M -$9.13M +$5.07M +35.7% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 -$55.7M -$16.8M -$6.53M -63.6% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$49.2M -$12.6M -$1.28M -11.3% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$47.9M -$12.1M -$5.41M -81.1% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$42.5M -$14.2M -$6.95M -95.9% 01 Oct 2020 31 Dec 2020 10-K 25 Mar 2022
Q3 2020 -$35.5M -$10.3M -$1.65M -19.1% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$33.9M -$11.3M -$7.63M -206% 01 Apr 2020 30 Jun 2020 10-Q 12 Nov 2021
Q1 2020 -$26.3M -$6.67M -$1.95M -41.3% 01 Jan 2020 31 Mar 2020 10-Q 12 Nov 2021
Q4 2019 -$24.3M -$7.25M +$7.32M +50.2% 01 Oct 2019 31 Dec 2019 10-K 05 Mar 2020
Q3 2019 -$31.6M -$8.63M +$6.44M +42.7% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$38.1M -$3.7M +$12.1M +76.5% 01 Apr 2019 30 Jun 2019 10-Q 12 Nov 2020
Q1 2019 -$50.1M -$4.72M +$11.2M +70.4% 01 Jan 2019 31 Mar 2019 10-Q 12 Nov 2020
Q4 2018 -$61.4M -$14.6M -$1.49M -11.3% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2020
Q3 2018 -$59.9M -$15.1M -$2.48M -19.7% 01 Jul 2018 30 Sep 2018 10-K 05 Mar 2020
Q2 2018 -$57.4M -$15.8M -$2.43M -18.2% 01 Apr 2018 30 Jun 2018 10-K 05 Mar 2020
Q1 2018 -$55M -$16M -$2.95M -22.6% 01 Jan 2018 31 Mar 2018 10-K 05 Mar 2020
Q4 2017 -$52M -$13.1M -$2.65M -25.3% 01 Oct 2017 31 Dec 2017 10-K 05 Mar 2020
Q3 2017 -$49.4M -$12.6M +$2.09M +14.2% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 -$51.5M -$13.3M +$1.68M +11.2% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$53.2M -$13M +$4.73M +26.6% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2017
Q4 2016 -$57.9M -$10.4M +$12.7M +55% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019
Q3 2016 -$70.6M -$14.7M +$5.21M +26.2% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$75.8M -$15M +$2.73M +15.4% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 -$78.6M -$17.7M -$4.26M -31.7% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$74.3M -$23.2M -$12.2M -112% 01 Oct 2015 31 Dec 2015 10-K 09 Mar 2018
Q3 2015 -$62M -$19.9M -$5.2M -35.4% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$56.8M -$17.8M -$11.4M -177% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 -$45.5M -$13.5M -$9.01M -202% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 -$36.5M -$10.9M 01 Oct 2014 31 Dec 2014 10-K 10 Mar 2017
Q3 2014 -$14.7M -$11.2M -319% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$6.4M -$3.26M -104% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$4.46M 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q3 2013 -$3.5M 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$3.14M 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014

Larimar Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$80.6M -$43.7M -118% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025
2023 -$36.9M -$1.59M -4.51% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025
2022 -$35.4M +$15.3M +30.2% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024
2021 -$50.6M -$8.15M -19.2% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 -$42.5M -$19.4M -83.7% 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
2019 -$23.1M +$38.2M +62.3% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021
2018 -$61.4M -$9.34M -18% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020
2017 -$52M +$5.85M +10.1% 01 Jan 2017 31 Dec 2017 10-K 05 Mar 2020
2016 -$57.9M +$16.4M +22.1% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 -$74.3M -$37.8M -104% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018
2014 -$36.5M -$22.5M -160% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 -$14M -$147K -1.06% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016
2012 -$13.9M 01 Jan 2012 31 Dec 2012 10-K 25 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.